Abbott Laboratories Share Price Cinnober Boat
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
| Market Cap | 167B 149B 139B 127B 238B 16,114B 242B 1,681B 651B 8,214B 628B 614B 26,443B | P/E 2026 * |
27.4x | P/E 2027 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise Value | 191B 170B 159B 145B 272B 18,419B 276B 1,921B 744B 9,389B 718B 702B 30,226B | EV / Sales 2026 * |
3.81x | EV / Sales 2027 * | 3.45x |
| Free-Float |
86.16% | Yield 2026 * |
2.66% | Yield 2027 * | 2.83% |
Last Transcript: Abbott Laboratories
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 15/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 171B | |
| -2.17% | -6.57% | -27.81% | -0.17% | 171B | |
| +0.17% | -3.20% | -9.24% | +10.31% | 110B | |
| -0.88% | -0.16% | -26.16% | -0.11% | 106B | |
| -0.69% | -3.57% | -47.61% | -12.45% | 75.99B | |
| +3.17% | -0.80% | -0.88% | +72.13% | 57.3B | |
| -0.52% | -2.44% | -4.86% | -31.12% | 48.76B | |
| +3.44% | +7.90% | +19.12% | +59.15% | 50.19B | |
| -0.85% | -0.82% | -18.96% | +18.41% | 41.14B | |
| -0.07% | -1.71% | +28.15% | -7.58% | 32.56B | |
| Average | +0.53% | -1.46% | -9.81% | +12.06% | 77B | |
| Weighted average by Cap. | +0.46% | -2.07% | -16.38% | +9.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.21B 44.66B 41.73B 38.05B 71.41B 4,835B 72.47B 504B 195B 2,465B 188B 184B 7,935B | 54.53B 48.5B 45.32B 41.32B 77.56B 5,252B 78.71B 548B 212B 2,677B 205B 200B 8,618B |
| Net income | 6.3B 5.61B 5.24B 4.78B 8.97B 607B 9.1B 63.32B 24.53B 309B 23.66B 23.15B 996B | 7.98B 7.1B 6.63B 6.05B 11.35B 768B 11.52B 80.14B 31.04B 392B 29.95B 29.3B 1,261B |
| Net Debt | 23.94B 21.29B 19.9B 18.14B 34.05B 2,306B 34.56B 240B 93.16B 1,175B 89.87B 87.92B 3,783B | 20.96B 18.64B 17.42B 15.88B 29.81B 2,018B 30.25B 211B 81.55B 1,029B 78.68B 76.97B 3,312B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
